Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1656
This examiner grants 31% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17938048 | METHODS FOR ANTIOXIDATION, REDUCING THE RISK OF OSTEOPOROSIS AND IMPROVING IMMUNITY BY USING MAGNETIZED ELDERBERRY FERMENT | Final Rejection | TCI CO., LTD. |
| 18000381 | RECOMBINANT EXPRESSION VECTOR FOR PRODUCTION OF ENCAPSULIN-BASED VACCINE AND METHOD FOR MANUFACTURING THE SAME | Non-Final OA | INTHERA INC. |
| 18501724 | METHODS AND COMPOSITIONS USING AN ENGINEERED RELEASE FACTOR | Non-Final OA | Opentrons Labworks Inc. |
| 17996441 | A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTEIN HAVING A MANNOSE-TERMINATED N-GLYCAN | Final Rejection | WUXI BIOLOGICS IRELAND LIMITED |
| 17980387 | SUPEROXIDE DISMUTASE COMPOSITIONS AND METHODS | Final Rejection | Blue Sky Innovations, LLC |
| 17917016 | IMPROVED METHODS OF PRODUCING A LIPIDATED PROTEIN | Non-Final OA | Valneva Austria GmbH |
| 17775704 | POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII | Non-Final OA | CSL BEHRING LENGNAU AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy